Literature DB >> 9259323

Activities in Pit-1 determine whether receptor interacting protein 140 activates or inhibits Pit-1/nuclear receptor transcriptional synergy.

F M Chuang1, B L West, J D Baxter, F Schaufele.   

Abstract

Pituitary-specific transcription of the evolutionarily related rat (r) GH and PRL genes involves synergistic interactions between Pit-1 and other promoter-binding factors including nuclear receptors. We show that Pit-1/thyroid hormone receptor (TR) and Pit-1/estrogen receptor (ER) synergistic activation of the rGH and rPRL promoters are globally similar. Both synergies depend upon the same activation functions in Pit-1 and also require activation function-2 conserved in TR and ER. The activation function-2 binding protein, RIP140, previously thought to be a nuclear receptor coactivator, strongly inhibits both Pit-1/TR and Pit-1/ER synergy. RIP140 inhibition is profoundly influenced, in a promoter-specific fashion, by a synergism-selective function in Pit-1: deletion of Pit-1 amino acids 72-100 switches RIP140 to an activator of Pit-1/ER and Pit-1/TR synergy at the rPRL promoter but not at the rGH promoter. Pit-1 amino acids 101-125 are required for RIP140 inhibition or activation again only at the rPRL promoter. Therefore, functions within one factor can determine the activity of a coactivator binding to its synergistic partner. This promoter context-specific synergistic interplay between transcription factors and coactivators is likely an essential determinant of cell-specific transcriptional regulation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9259323     DOI: 10.1210/mend.11.9.9978

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  6 in total

1.  A Pit-1 threonine 220 phosphomimic reduces binding to monomeric DNA sites to inhibit Ras and estrogen stimulation of the prolactin gene promoter.

Authors:  Annie Jean; Arthur Gutierrez-Hartmann; Dawn L Duval
Journal:  Mol Endocrinol       Date:  2009-11-03

2.  Cloning and characterization of mouse RIP140, a corepressor for nuclear orphan receptor TR2.

Authors:  C H Lee; C Chinpaisal; L N Wei
Journal:  Mol Cell Biol       Date:  1998-11       Impact factor: 4.272

3.  Modulation of lysine acetylation-stimulated repressive activity by Erk2-mediated phosphorylation of RIP140 in adipocyte differentiation.

Authors:  Ping-Chih Ho; Pawan Gupta; Yao-Chen Tsui; Sung Gil Ha; Mostaqul Huq; Li-Na Wei
Journal:  Cell Signal       Date:  2008-07-05       Impact factor: 4.315

4.  Functional sequestration of transcription factor activity by repetitive DNA.

Authors:  Xiaowei Liu; Bo Wu; Jaroslaw Szary; Eric M Kofoed; Fred Schaufele
Journal:  J Biol Chem       Date:  2007-05-25       Impact factor: 5.157

5.  CCAAT/enhancer binding protein alpha uses distinct domains to prolong pituitary cells in the growth 1 and DNA synthesis phases of the cell cycle.

Authors:  Weiqun Liu; John F Enwright; William Hyun; Richard N Day; Fred Schaufele
Journal:  BMC Cell Biol       Date:  2002-03-21       Impact factor: 4.241

6.  Pituitary changes in Prop1 transgenic mice: hormone producing tumors and signet-ring type gonadotropes.

Authors:  Noboru Egashira; Takeo Minematsu; Syunsuke Miyai; Susumu Takekoshi; Sally A Camper; Robert Y Osamura
Journal:  Acta Histochem Cytochem       Date:  2008-06-27       Impact factor: 1.938

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.